Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT04514497
Ignite Creation Date: 2024-05-06 @ 3:03 PM
Last Modification Date: 2024-10-26 @ 1:42 PM
Study NCT ID: NCT04514497
Protocol Section: NCT04514497
Start Identification Module Data
Expand Identification Module Data
Brief Title: Testing the Addition of an Anti-cancer Drug BAY 1895344 to Usual Chemotherapy for Advanced Stage Solid Tumors With a Specific Focus on Patients With Small Cell Lung Cancer Poorly Differentiated Neuroendocrine Cancer and Pancreatic Cancer
Official Title: BAY 1895344 Plus Topoisomerase-1 Top1 Inhibitors in Patients With Advanced Solid Tumors Phase I Studies With Expansion Cohorts in Small Cell Lung Carcinoma SCLC Poorly Differentiated Neuroendocrine Carcinoma PD-NEC and Pancreatic Adenocarcinoma PDA
Acronym: None
Organization: National Cancer Institute NCI
Organization Class: NIH
Organization Study ID: NCI-2020-05958
Secondary IDs
Secondary ID Type Domain Link
UM1CA186689 NIH CTEP httpsreporternihgovquickSearchUM1CA186689
NCI-2020-05958 REGISTRY None None
10402 OTHER None None
10402 OTHER None None
Start Status Module Data
Status Verified Date: 2024-09
Overall Status: ACTIVE_NOT_RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: National Cancer Institute NCI
Lead Sponsor Class: NIH
Lead Sponsor: National Cancer Institute NCI
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload